Figures & data
Table 1 Baseline characteristics of patients with and without exacerbation
Figure 1 Flow diagram of the included study participants.
![Figure 1 Flow diagram of the included study participants.](/cms/asset/a041a173-4b72-4354-9d4f-0687f3554446/dcop_a_149805_f0001_c.jpg)
Figure 2 Correlation of CAT and CCQ scores with SGRQ (A and D), FEV1% predicted (B and E), and 6MWD (C and F).
![Figure 2 Correlation of CAT and CCQ scores with SGRQ (A and D), FEV1% predicted (B and E), and 6MWD (C and F).](/cms/asset/484c4018-c5e6-4d41-aaeb-502436a4d673/dcop_a_149805_f0002_c.jpg)
Table 2 Predictors of exacerbation during 1-year follow-up period